Archive: 25/01/2017

Diabetes drug takes aim at cancer's fuel source

In the last three years, researchers have shown that diabetic patients with head and neck cancer, may have better outcomes than non-diabetic patients when they are taking the drug metformin for their diabetes. In order to ...

Improving the accuracy of TB testing

Tuberculosis (TB) affects some 35-million people globally. In 2009 testing for TB using molecular diagnostics proved a game-changer for national TB programmes.

page 5 from 10